Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123973484 | 12397348 | 4 | F | 2016 | 20160627 | 20160524 | 20160706 | PER | US-PFIZER INC-2016260681 | PFIZER | 57.00 | YR | F | Y | 0.00000 | 20160706 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123973484 | 12397348 | 1 | PS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 50 MG TABLET AT 11AM | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | QD | |||||||
123973484 | 12397348 | 2 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 300 MG, UNK | 0 | 300 | MG | |||||||||
123973484 | 12397348 | 3 | C | TEMAZEPAM. | TEMAZEPAM | 1 | 15 MG, AT NIGHT 10:30PM | 0 | 15 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123973484 | 12397348 | 1 | Depression |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123973484 | 12397348 | Dry skin | |
123973484 | 12397348 | Dyspepsia | |
123973484 | 12397348 | Urine odour abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123973484 | 12397348 | 1 | 201604 | 0 |